Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
- PMID: 2225067
- DOI: 10.1016/0092-8674(90)90455-n
Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication
Abstract
Overexpression of TAR-containing sequences (TAR decoys) was used to render cells resistant to HIV replication. A chimeric tRNA(meti)-TAR transcription unit contained in a double copy murine retroviral vector was used to express high levels of HIV-1 TAR-containing transcripts in CEM SS cells. Replication of HIV-1 was inhibited over 99% in cells expressing chimeric tRNA-TAR transcripts, but an amphotropic murine retrovirus replicated normally in these cells. Expression of TAR sequences in CEM SS cells had no adverse effects on cell viability, indicating that essential cellular factors are not being sequestered in these cells. TAR decoy RNA-mediated HIV inhibition may also be effective against natural HIV isolates in spite of their hypervariable nature, as suggested by the fact that replication of SIVmac was also inhibited in cells expressing HIV-1 TAR decoys.
Similar articles
-
Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells.New Biol. 1992 Jan;4(1):66-74. New Biol. 1992. PMID: 1536832
-
Analysis of trans-acting response decoy RNA-mediated inhibition of human immunodeficiency virus type 1 transactivation.J Virol. 1991 Dec;65(12):6811-6. doi: 10.1128/JVI.65.12.6811-6816.1991. J Virol. 1991. PMID: 1942253 Free PMC article.
-
Inhibition of HIV-1 in CEM cells by a potent TAR decoy.Gene Ther. 1995 Aug;2(6):377-84. Gene Ther. 1995. PMID: 7584112
-
Exosomal packaging of trans-activation response element (TAR) RNA by HIV-1 infected cells: a pro-malignancy message delivery to cancer cells.Mol Biol Rep. 2019 Jun;46(3):3607-3612. doi: 10.1007/s11033-019-04770-2. Epub 2019 Mar 22. Mol Biol Rep. 2019. PMID: 30903574 Review.
-
TAR decoys and trans-dominant gag mutant for HIV-1 gene therapy.Antibiot Chemother (1971). 1996;48:192-7. doi: 10.1159/000425177. Antibiot Chemother (1971). 1996. PMID: 8726525 Review. No abstract available.
Cited by
-
Developing aptamers into therapeutics.J Clin Invest. 2000 Oct;106(8):929-34. doi: 10.1172/JCI11325. J Clin Invest. 2000. PMID: 11032851 Free PMC article. No abstract available.
-
Therapeutic Potential of Aptamer-Protein Interactions.ACS Pharmacol Transl Sci. 2022 Nov 4;5(12):1211-1227. doi: 10.1021/acsptsci.2c00156. eCollection 2022 Dec 9. ACS Pharmacol Transl Sci. 2022. PMID: 36524009 Free PMC article. Review.
-
Gene therapy for HIV.Sex Transm Infect. 2001 Apr;77(2):93-6. doi: 10.1136/sti.77.2.93. Sex Transm Infect. 2001. PMID: 11287684 Free PMC article. Review. No abstract available.
-
RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production.J Virol. 2011 Jan;85(1):305-14. doi: 10.1128/JVI.02626-09. Epub 2010 Oct 27. J Virol. 2011. PMID: 20980522 Free PMC article.
-
RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.Nucleic Acids Res. 1998 Sep 15;26(18):4160-7. doi: 10.1093/nar/26.18.4160. Nucleic Acids Res. 1998. PMID: 9722635 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources